Loading…
arrow_back View All Dates
Tuesday, June 17
 

6:30am EDT

8:00am EDT

8:30am EDT

9:30am EDT

9:45am EDT

10:30am EDT

#215: The Need for a Multi-Stakeholder Collaboration to Modernize ICSR Management: How? Why? What? 150AB #216: The Globalization of Risk Management 207A #217: Case Studies of Application of AI in Risk-Based Quality Management 209ABC #219: Resilient Leadership: Overcoming Isolation and Adversity 151A #220: Novel Framework and Case Study to Support Scientific Rigor: A New Community-Focused Model for Sustainable Clinical Trial Participation 202A #221: Participant Compensation in Clinical Trials: Exploring Today’s Landscape and Unlocking Opportunities 201 #222: Innovative Regulatory Approaches for Developing Diagnostic Tests for Rare Biomarkers 204ABC #223: Transforming the Project Management Role to Meet the Emerging Needs in Pharma: Extending Scope from R&D Focus to Launch Projects 151B #224: FDA, MHRA, Health Canada Views on Data Flow: The Backbone of Effective Risk Assessments in Innovative Clinical Trial Design and Conduct 152AB #225: Pathways to Innovation: Navigating Regulatory Expectations for AI Technologies in Drug Development 147AB #226: US and EU Orphan Drug Regulations: Shaping the Ecosystem for Rare Diseases 146BC #227: ANVISA Town Hall 145AB #218: Innovation Reimagined: How Intelligent Automation is Redefining Research and Development Excellence 207B #228: Advancing a Global Regulatory Approach to Pharmaceutical Quality Knowledge Management 143ABC #229: Bayesian Benefit-Risk Analysis: A Framework for Quantitative Evidence-Based Decision Making in Medical Product Development 144ABC #230: Banishing Burnout: A Practice of Mindfulness Tools to Reduce Stress and Improve Well-Being 206

11:00am EDT

11:30am EDT

11:40am EDT

11:45am EDT

12:00pm EDT

12:25pm EDT

1:00pm EDT

1:05pm EDT

1:45pm EDT

2:45pm EDT

2:55pm EDT

3:00pm EDT

4:00pm EDT

#261: Advancing Premarketing Safety Analytics through FDA and Industry Partnerships 207A #262: Overcoming Site Burden: Driving Adoption of Automation and End-to-End Integration 202A #263: Using Generative AI to Explore our Track Record on Paying Participants: What Can We Learn to Support More Diverse Representation 209ABC #264: How Do We Get from Here to There: Putting Real-World Data Quality Assessments into Practice 207B #265: Breaking Barriers: Making Health Information Accessible to All 151A #270: Patient Engagement in Trial Design and the Evolving Landscape of FDA, EMA and Country Authority Guidance 146BC #266: Opportunities for Innovation Under Fragmented Regulatory Framework for Clinical Development of Medicines and Diagnostics 204ABC #267: Delivering Effective Business Transformations and How to Apply them to Drug Development 151B #268: New Data and Insights on the Vendor Qualification Process in Drug Development 150AB #269: Pharmacovigilance Inspections Fireside Chat 152AB #271: Enhancing Global Access to Innovative Therapies: Regulatory Convergence, Harmonization, and Collaboration in Advanced Therapy Medicinal Products 147AB #272: Towards Instantaneous Regulatory Decisions and Better Predictability 145AB #273: Regulatory Cooperation Between US and Japan Salon B #274: Global Collaborative Review: Understanding Overall Control Strategy and Patient Benefit-Risk 143ABC #275: Externally Controlled Trials in Clinical Development: Challenges and Mitigation Strategies 144ABC #276: Exploring Regulator Career Paths: How Breadth of Experience Informs Decision Making and Medicines Development? 206 #277: Getting the Work of Medicines Development and Manufacturing Done by Hook or by Crook: Attracting, Retaining and Developing Key Talent in the New World of Work 201

6:45pm EDT

 
  • Filter By Date
    Jun 9 - 19, 2025
    June 2025
    SunMonTueWedThuFriSat
    1234567
    891011121314
    15161718192021
    22232425262728
    2930 
  • Filter By Venue
  • Filter By Type
  • Level
  • Keyword
  • Timezone

Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date -